Fabian Badtke, LLM (Cambridge)

Rechtsanwalt (Lawyer), Partner

Antitrust & Competition
Life Sciences
Compliance & Investigations
Regulatory and Governmental Affairs

Fabian Badtke

Fabian Badtke heads the firm’s antitrust and competition group. He advises and represents national and international clients on all aspects of European and German antitrust law, including merger control and coordination of multi-jurisdictional filings, antitrust investigations, behavioural matters, antitrust litigation and compliance programmes. Fabian has particular industry know-how in the financial services, healthcare and life sciences, retail and media sectors.


  • DAF Trucks / Paccar in the defence against numerous antitrust damages claims brought before German courts
  • ICON on its $12bn acquisition of PRA Health Sciences
  • RIB Software on a €1.4bn public takeover bid by Schneider Electric
  • Fresenius/Helios: Advising on its €3bn acquisition of 40 hospitals and 13 medical care centres from Rhoen Klinikum
  • Fresenius Kabi on the implementation of a Europe-wide antitrust compliance program
  • ThyssenKrupp: Advising the company on its internal compliance investigations
  • ABN AMRO: Advising on the acquisition of Credit Suisse´s private banking business in Germany


  • Frequently recommended lawyer for antitrust law (JUVE Handbook, on-going since 2017; “really good, very pragmatic” (client), “ambitious and dedicated” (competitor))
  • Frequently recommended by GCR Competition Review in “Who’s Who Legal: Competition – Future Leaders” (“really impressive for merger filings” and also “well known for his strong antitrust practice, receiving international endorsements for his work on complex cartel damages claims”)
  • Recommended advisor for healthcare antitrust law (JUVE 2021/2022, "very satisfied, excellent lawyer in whom we have great confidence" (client))
  • Top lawyer for antitrust and competition, German business weekly WirtschaftsWoche (2021)
  • Frequently listed as an "antitrust Cartel law expert", " in Germany’s "Handelsblatt" newspaper
  • In 2008, he was awarded a prize for the best dissertation in competition law, corporate law and intellectual property rights by the Humboldt-University of Berlin


  • Legal studies at the Universities of Potsdam and Cambridge, (UK)  (LL.M.) and at the Humboldt-University of Berlin
  • Secondment to Deutsche Bank (2014)
  • Experience as a lawyer in a law firm specialising in medical law in Berlin
  • At Noerr since 2007
  • Admitted to the Berlin Chamber of Lawyers since 2006


  • American Bar Association (ABA), Antitrust Section
  • Member of the antitrust research association Studienvereinigung Kartellrecht
  • KartellrechtsForum Frankfurt am Main
  • International Bar Association (IBA)


  • Regular activity as moderator and speaker at the annual Noerr Competition Day
  • Regular live-webinars on antitrust litigation, antitrust compliance and distribution law


  • Antitrust in the financial services sector, Bankrecht, 6th ed. 2022, Carl Heymanns Verlag
  • Antitrust and R&D agreements, Verträge über Forschung und Entwicklung, 3rd ed. 2018, Carl Heymanns Verlag
  • Wer zahlt Kartellbußen? – Bundesarbeitsgericht zur Managerhaftung, Frankfurter Allgemeine Zeitung 28/06/2017, Recht und Steuern
  • Aktuelle Entwicklungen beim Akteneinsichtsrecht in Wettbewerbsverfahren (with Jan Moritz Lang), Wirtschaft und Wettbewerb (WuW 2016)
  • Should the Acquisition of Non-controlling Minority Shareholdings be Treated as Concentra-tions? (with Rea Diamantatou), Journal of European Competition Law & Practice, 2016, Vol. 7
  • Kollektive Marktbeherrschung im Kraftstoffmarkt? (with Dr Oliver Vahrenholt), Zeitschrift für Wettbewerbsrecht (ZWeR), 2012
  • Die Bedeutung des Kartellrechts bei M&A-Transaktionen, Kölner Schrift zum Wirtschaftsrecht (KSzW), 2011
  • Das Kartellrecht und die aktuelle Debatte um die Laufzeitverlängerung von Atomkraftwerken – eine kritische Würdigung (with Oliver Vahrenholt), Wettbewerb in Recht und Praxis (WRP) 2010
  • Der “Rhön-Beschluss” des BGH – endlich Klarheit bei der Zusammenschlusskontrolle von Krankenhausfusionen?, Zeitschrift für das gesamte Krankenhausrecht (KHR), 2008
  • Die Anwendbarkeit der deutschen und europäischen Fusionskontrolle auf Zusammenschlüsse von Krankenhäusern, Nomos Verlag, 2008
  • Die kartellrechtliche Bewertung des “AOK-Modells” beim Abschluss von Rabattverträgen, Wirtschaft und Wettbewerb (WuW), 2007